
The Delhi High Court recently passed an injunction order restraining a slew of generic pharmaceutical firms including Windlas Biotech, Natco and Torrent Pharma from manufacturing or selling Valsartan and Sacubitril Tablets, patented in favour of Novartis (Novartis AG & Ors. v. NATCO Pharma Limited)
We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.